Homocysteine and Erythrocyte Sedimentation Rate Correlate with Cerebrovascular Disease in Fabry Disease
Authors:
- 1 February 2012
- book chapter
- Published by Springer Nature
- Vol. 6, 101-105
Abstract
Cerebrovascular disease (CVD) is a common clinical problem in Fabry disease; however, expression of this disease manifestation is not uniform and risk factors for its development are not well studied. A number of common CVD risk factors are known in the general population, and these may also play a role in the development of CVD in Fabry disease. To evaluate the potential associations between various risk factors and CVD in patients with Fabry disease. Thirty-two Fabry disease patients were studied, with 15 having evidence of CVD. T-tests were used to compare the positive and negative CVD groups and logistic regression was used to look for correlations with CVD history. CVD-positive patients were older (49.73 vs. 37.59 years, p2, p < 0.005), higher homocysteine (17.79 vs. 10.53 μmol/L, p < 0.05) and erythrocyte sedimentation rate (ESR) levels (23.8 vs. 7.64 mm/h, p < 0.001), and elevated Mainz Severity Score Index (MSSI) scores (23.8 vs. 11.8, p < 0.001). Correlations were found between age (odds ratio (OR) 1.11), DTPA glomerular filtration rate (OR 0.95), homocysteine concentration (OR 1.22), ESR (OR 1.16) and the MSSI (OR 1.19) scores with a positive CVD history (all p < 0.05). Elevated homocysteine and ESR are independent risk factors for CVD in Fabry disease. This finding adds to our ability to predict those patients with Fabry disease who are at a higher risk of developing CVD, and may be an aid in deciding which patients should have primary CVD prevention therapies.Keywords
This publication has 23 references indexed in Scilit:
- Meta-Analysis of Folic Acid Supplementation Trials on Risk of Cardiovascular Disease and Risk Interaction With Baseline Homocysteine LevelsThe American Journal of Cardiology, 2010
- Efficacy of Homocysteine-Lowering Therapy With Folic Acid in Stroke PreventionStroke, 2010
- Belgian Fabry StudyStroke, 2010
- Mutations of the GLA Gene in Young Patients With StrokeStroke, 2010
- Frequency of Unrecognized Fabry Disease Among Young European-American and African-American Men With First Ischemic StrokeStroke, 2010
- Decreased Nitric Oxide Bioavailability in a Mouse Model of Fabry DiseaseJournal of the American Society of Nephrology, 2009
- Elevated globotriaosylsphingosine is a hallmark of Fabry diseaseProceedings of the National Academy of Sciences, 2008
- Correlation between interleukin‐6 promoter and C‐reactive protein (CRP) polymorphisms and CRP levels with the Mainz Severity Score Index for Fabry diseaseJournal of Inherited Metabolic Disease, 2008
- Magnetic resonance imaging changes in Fabry diseaseActa Paediatrica, 2006
- Early Prediction of Stroke SeverityStroke, 1995